• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Editorial
Unveiling GULP1 as a Hepatocyte-Specific Role for Recurrence: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”
Pengde Lu, Ning Wang
School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong S.A.R., P.R. China
Correspondence :  Ning Wang ,
Email: ckwang@hku.hk
Received: March 11, 2025   Accepted: March 15, 2025
KeyWords: Hepatocellular carcinoma; Recurrence; GULP1; Biomarker; Prediction
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 272 View
  • 19 Download
Related articles

GULP1, A Multifaceted Diagnostic Biomarker and Potential Therapeutic Target in Hepatocellular Carcinoma: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

Correspondence: Response to the Letter Regarding "GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma"

Letter “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

Screening of patients at high risk of de novo recurrence in HCC: Editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”2025 April;31(2)

GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 430
TOTAL : 2652751
Close layer